Login / Signup

Longitudinal profiling of human blood transcriptome in healthy and lupus pregnancy.

Seunghee HongRomain BanchereauBat-Sheva L MaslowMarta M GuerraJacob CardenasJeanine BaischD Ware BranchT Flint PorterAllen SawitzkeCarl A LaskinJill P BuyonJoan MerrillLisa R SammaritanoMichelle A PetriElizabeth GatewoodAlma-Martina CepikaMarina OhouoGerlinde ObermoserEsperanza AnguianoTae Whan KimJohn NulsenDjamel Nehar-BelaidDerek BlankenshipJacob TurnerJacques F BanchereauJane E SalmonVirginia Pascual
Published in: The Journal of experimental medicine (2019)
Systemic lupus erythematosus carries an increased risk of pregnancy complications, including preeclampsia and fetal adverse outcomes. To identify the underlying molecular mechanisms, we longitudinally profiled the blood transcriptome of 92 lupus patients and 43 healthy women during pregnancy and postpartum and performed multicolor flow cytometry in a subset of them. We also profiled 25 healthy women undergoing assisted reproductive technology to monitor transcriptional changes around embryo implantation. Sustained down-regulation of multiple immune signatures, including interferon and plasma cells, was observed during healthy pregnancy. These changes appeared early after embryo implantation and were mirrored in uncomplicated lupus pregnancies. Patients with preeclampsia displayed early up-regulation of neutrophil signatures that correlated with expansion of immature neutrophils. Lupus pregnancies with fetal complications carried the highest interferon and plasma cell signatures as well as activated CD4+ T cell counts. Thus, blood immunomonitoring reveals that both healthy and uncomplicated lupus pregnancies exhibit early and sustained transcriptional modulation of lupus-related signatures, and a lack thereof associates with adverse outcomes.
Keyphrases